278 related articles for article (PubMed ID: 12767705)
1. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines.
Lo YL
J Control Release; 2003 Jun; 90(1):37-48. PubMed ID: 12767705
[TBL] [Abstract][Full Text] [Related]
2. Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats.
Lo YL
Biochem Pharmacol; 2000 Nov; 60(9):1381-90. PubMed ID: 11008132
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats.
Lo YL; Huang JD
Biochem Pharmacol; 2000 Mar; 59(6):665-72. PubMed ID: 10677583
[TBL] [Abstract][Full Text] [Related]
4. Effect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestines.
Lo Y; Liu F; Cherng J
J Control Release; 2001 Sep; 76(1-2):1-10. PubMed ID: 11532308
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid.
Lo YL; Liu FI; Yang JM; Cherng JY
Anticancer Res; 2001; 21(1A):445-50. PubMed ID: 11299776
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line.
Lo YL; Hsu CY; Huang JD
Anticancer Res; 1998; 18(4C):3005-9. PubMed ID: 9713500
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients.
Yamagata T; Kusuhara H; Morishita M; Takayama K; Benameur H; Sugiyama Y
Drug Metab Dispos; 2007 Jul; 35(7):1142-8. PubMed ID: 17446265
[TBL] [Abstract][Full Text] [Related]
8. Site-specific bidirectional efflux of 2,4-dinitrophenyl-S-glutathione, a substrate of multidrug resistance-associated proteins, in rat intestine and Caco-2 cells.
Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
J Pharm Pharmacol; 2007 Apr; 59(4):513-20. PubMed ID: 17430634
[TBL] [Abstract][Full Text] [Related]
9. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
Lo YL; Ho CT; Tsai FL
Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
Mo R; Xiao Y; Sun M; Zhang C; Ping Q
Int J Pharm; 2011 May; 409(1-2):38-45. PubMed ID: 21356302
[TBL] [Abstract][Full Text] [Related]
11. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
Sha X; Fang X
Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effects of Benzaldehyde, Vanillin, Muscone and Borneol on P-Glycoprotein in Caco-2 Cells and Everted Gut Sac.
Wang S; Tan N; Ma C; Wang J; Jia P; Liu J; Yang Y; Xie Z; Zhao K; Zheng X
Pharmacology; 2018; 101(5-6):269-277. PubMed ID: 29502118
[TBL] [Abstract][Full Text] [Related]
14. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
15. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
16. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.
Shono Y; Nishihara H; Matsuda Y; Furukawa S; Okada N; Fujita T; Yamamoto A
J Pharm Sci; 2004 Apr; 93(4):877-85. PubMed ID: 14999725
[TBL] [Abstract][Full Text] [Related]
17. Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats.
Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
J Pharm Pharmacol; 2007 Sep; 59(9):1263-70. PubMed ID: 17883898
[TBL] [Abstract][Full Text] [Related]
18. Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates M; Kaynak MS; Sahin S
J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
[TBL] [Abstract][Full Text] [Related]
19. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.
Shen Q; Lin Y; Handa T; Doi M; Sugie M; Wakayama K; Okada N; Fujita T; Yamamoto A
Int J Pharm; 2006 Apr; 313(1-2):49-56. PubMed ID: 16500056
[TBL] [Abstract][Full Text] [Related]
20. Effects of pharmaceutical excipients on membrane permeability in rat small intestine.
Takizawa Y; Kishimoto H; Nakagawa M; Sakamoto N; Tobe Y; Furuya T; Tomita M; Hayashi M
Int J Pharm; 2013 Sep; 453(2):363-70. PubMed ID: 23742974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
